Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
9.00
+0.51 (6.01%)
Dec 10, 2025, 4:00 PM EST - Market closed
Sutro Biopharma Revenue
Sutro Biopharma had revenue of $9.69M in the quarter ending September 30, 2025, with 13.77% growth. This brings the company's revenue in the last twelve months to $105.65M, down -34.36% year-over-year. In the year 2024, Sutro Biopharma had annual revenue of $62.04M, down -59.64%.
Revenue (ttm)
$105.65M
Revenue Growth
-34.36%
P/S Ratio
0.71
Revenue / Employee
$340,794
Employees
310
Market Cap
76.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.04M | -91.69M | -59.64% |
| Dec 31, 2023 | 153.73M | 85.96M | 126.84% |
| Dec 31, 2022 | 67.77M | 5.89M | 9.52% |
| Dec 31, 2021 | 61.88M | 19.16M | 44.84% |
| Dec 31, 2020 | 42.72M | -14.00K | -0.03% |
| Dec 31, 2019 | 42.74M | 4.32M | 11.24% |
| Dec 31, 2018 | 38.42M | -13.32M | -25.75% |
| Dec 31, 2017 | 51.74M | -67.72M | -56.69% |
| Dec 31, 2016 | 119.46M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
STRO News
- 4 weeks ago - Sutro Biopharma, Inc. (STRO) Discusses Strategic Reset and Progress in Next-Generation ADC Pipeline and Platform Innovation Transcript - Seeking Alpha
- 4 weeks ago - Sutro Biopharma Reports Third Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 5 weeks ago - Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025 - GlobeNewsWire
- 5 weeks ago - Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference - GlobeNewsWire
- 2 months ago - Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones - GlobeNewsWire
- 4 months ago - Sutro Biopharma Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 7 months ago - Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 7 months ago - Sutro Biopharma to Participate in Upcoming Investor Conferences - GlobeNewsWire